Assouly-Besse F, Seletti B, Lamarque I, Elghozi D, Petitjean F
Centre Hospitalier René Dubos, Pontoise.
Ann Med Psychol (Paris). 1996 Jun;154(4):259-63.
Polydipsia can be defined as an impulsive behavior leading to absorption of large amounts of water (4 to 20 litres a day), without any underlying organic disease. Its prevalence in a population of chronic psychiatric patients can be as high as 6 to 17%. Schizophrenia represents 80% of cases reported. Some patients with polydipsia may develop hyponatremia, leading to a PIP syndrome (Polydipsia intermittent hyponatremia and psychosis). Hyponatremia or water intoxication appears when three conditions are present: an abnormal regulation of thirst, an inappropriate ADH secretion and/or an excessive renal sensitivity to ADH, with an increased sensitivity of the central nervous system to hyponatremia. The clinician must first identify patients at risk to develop water intoxication and start treatment before any severe physical complication occurs. Pharmacological treatments aiming at an increase of renal free-water excretion--do not show a constant efficacy in the correction of hyponatremia, they have no action on polydipsia. The new atypical neuroleptics such as clozapine and risperidone seem to open new perspectives in the treatment of polydipsia. Controlled studies should be performed in this field.
烦渴可定义为一种冲动行为,导致大量饮水(每天4至20升),且无任何潜在器质性疾病。在慢性精神病患者群体中,其患病率可高达6%至17%。精神分裂症占报告病例的80%。一些烦渴患者可能会出现低钠血症,导致一种PIP综合征(烦渴、间歇性低钠血症和精神病)。当出现以下三种情况时会发生低钠血症或水中毒:口渴调节异常、抗利尿激素(ADH)分泌不当和/或肾脏对ADH过度敏感,同时中枢神经系统对低钠血症的敏感性增加。临床医生必须首先识别有发生水中毒风险的患者,并在任何严重身体并发症发生之前开始治疗。旨在增加肾脏自由水排泄的药物治疗——在纠正低钠血症方面并非始终有效,对烦渴也无作用。新型非典型抗精神病药物如氯氮平和利培酮似乎为烦渴治疗开辟了新前景。该领域应开展对照研究。